2025-08-25 - Analysis Report
Okay, here's a report analyzing Hims & Hers Health Inc (HIMS) based on the data provided.

## Hims & Hers Health Inc (HIMS) Analysis

Hims & Hers Health Inc (HIMS) is a telehealth company that provides personalized health and wellness solutions directly to consumers.

### 1. Performance vs. S&P 500 (VOO)

*   **HIMS Cumulative Return:** 169.04%
*   **VOO (S&P 500) Cumulative Return:** 38.83%
*   **Absolute Deviation (Current):** 99.3
*   **Relative Deviation (Current):** 49.7 (Indicates the current deviation is near the median compared to historical deviations).
*   **Deviation Range:** (min: -88.4, max: 288.9)

**Analysis:** HIMS has significantly outperformed the S&P 500 over the observed period. The current deviation suggests that while HIMS is still performing strongly, the gap between its performance and the S&P 500 is at the median of its historical range.

### Alpha, Beta Analysis

Here is the table summarizing the Alpha, Beta, and other values

| Year       | CAGR    | MDD   | Alpha   | Beta   | Cap(B) |
| ---------- | ------- | ----- | ------- | ------ | ------ |
| 2019-2021  | -46.0%  | 51.0% | -47.0%  | 0.1   | 1.5  |
| 2020-2022  | -15.0%  | 72.1% | -4.0%   | 0.1   | 1.4  |
| 2021-2023  | -51.0%  | 72.1% | -61.0%  | 0.0   | 2.0  |
| 2022-2024  | 127.0%  | 78.4% | 97.0%   | -0.0  | 5.5  |
| 2023-2025  | 164.0%  | 79.7% | 119.0%  | -0.0  | 10.1 |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):** Shows significant fluctuation with strong negative growth in earlier periods and extremely strong growth in the most recent periods.
*   **MDD (Maximum Drawdown):** High MDD values indicate significant risk and volatility in the stock's price.
*   **Alpha:** The negative alpha in earlier periods suggests underperformance relative to the market. The recent positive alpha indicates significant outperformance.
*   **Beta:** Beta values are low or negative, suggesting the stock is not strongly correlated with the overall market (S&P 500). A beta near 0 indicates little to no systematic risk.
*   **Cap(B):** The market capitalization has increased significantly over time, indicating growth in the company's value.

### 2. Recent Stock Price Movement

*   **Current Price:** $44.57
*   **Previous Close:** $43.96
*   **Change:** $1.39
*   **5-day Moving Average:** 43.838
*   **20-day Moving Average:** 52.2405
*   **60-day Moving Average:** 52.366

**Analysis:** The stock price has increased slightly from the previous close. The fact that the current price is below both the 20-day and 60-day moving averages suggests a potential short-term downtrend or consolidation phase, however, the jump in the price can indicate a short uptrend.

### 3. Technical Indicators & Expected Return

*   **Market Risk Indicator (MRI):** 0.3377 (Low Risk)
*   **RSI (Relative Strength Index):** 13.99 (Oversold)
*   **PPO (Percentage Price Oscillator):** -2.21
*   **Hybrid Signal:** cash_70%_Sell 0.1% of holdings (1 shares - Caution - MRI:0.33)
*   **Recent (20-day) Relative Deviation Change:** -1.6 (Negative - Short-term decline)
*   **Expected Return (%):** -15.2%

**Analysis:**

*   The **Low MRI** indicates a stable investment environment for the company.
*   The **RSI** is in oversold territory, suggesting the stock *might* be undervalued and could see a potential price rebound *if* there are no bad news.
*   The **PPO** is negative, confirming the short-term downtrend suggested by the moving averages.
*   The **Hybrid Signal** suggests selling a small portion (0.1%) of holdings and increasing cash position to 70% based on current indicators.
*   The **negative expected return** indicates that, based on current conditions, the model predicts HIMS may underperform the S&P 500 over a long-term investment horizon (2+ years).
*   The change of the recent price is 1.39, it indicates that there is a sharp rise in the price, so investors should monitor this fluctuation.

### 4. Recent News & Significant Events

*   **2025-08-25:** HIMS made headlines due to major business developments, regulatory changes, or market events.
*   **2025-08-23:** Analysts are discussing HIMS's recent performance and outlook.
*   **2025-08-24:** HIMS's stock has shown notable volatility.
*   **2025-08-22:** Market experts highlight both risks and opportunities for HIMS.

**Analysis:** Recent news indicates significant activity surrounding HIMS, including discussions about performance, volatility, and potential developments. Investors should closely monitor official company announcements and credible news sources for further details.

### 5. Recent Earnings Analysis:

| Date       | EPS  | Revenue |
| ---------- | ---- | ------- |
| 2025-08-04 | 0.19 | 0.54 B$ |
| 2025-05-05 | 0.22 | 0.59 B$ |
| 2024-11-04 | 0.35 | 0.40 B$ |
| 2024-08-05 | 0.06 | 0.32 B$ |
| 2025-08-04 | 0.06 | 0.32 B$ |

**Analysis:**

*   There is growth in EPS and Revenue, but 2025-08-04 data shows inconsistency. The company should keep the consistent growth and maintain the positive trend.

### 6. Financial Information:

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
| ------------ | --------- | ------------- |
| 2025-06-30   | $0.54B    | 76.39%        |
| 2025-03-31   | $0.59B    | 73.50%        |
| 2024-12-31   | $0.48B    | 76.81%        |
| 2024-09-30   | $0.40B    | 79.16%        |
| 2024-06-30   | $0.32B    | 81.30%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE       |
| ------------ | --------- | --------- |
| 2025-06-30   | $0.56B    | 7.55%     |
| 2025-03-31   | $0.55B    | 9.01%     |
| 2024-12-31   | $0.48B    | 5.46%     |
| 2024-09-30   | $0.44B    | 17.18%    |
| 2024-06-30   | $0.36B    | 3.67%     |

**Analysis:**

*   **Revenue and Profitability:** Revenue has generally been increasing, but Profit Margin has been decreasing slightly in recent quarters.
*   **Capital and Profitability:** Equity has been growing, which is a positive sign. ROE (Return on Equity) has fluctuated, with a recent decrease, indicating potentially reduced efficiency in generating profit from equity.

### 7. 종합 Analysis

Hims & Hers Health Inc. has shown strong growth and significant outperformance compared to the S&P 500. However, recent technical indicators and financial data suggest potential short-term headwinds.

**Key Takeaways:**

*   **Growth & Outperformance:** HIMS has demonstrated significant growth and outperformed the S&P 500 substantially in the past.
*   **Recent Downtrend:** Technical indicators (price below moving averages, negative PPO, oversold RSI) suggest a possible short-term downtrend or consolidation.
*   **Volatility:** The stock exhibits high volatility, as evidenced by the wide range of historical deviations and recent news.
*   **Financial Health:** Revenue and equity are growing, but profit margins and ROE have shown some recent declines.
*   **Hybrid Signal:** The hybrid signal recommended a 70% cash position, suggesting a cautious approach.
*   **Caution:** Investors should carefully monitor recent news, earnings reports, and company announcements to make informed decisions.
